
- Pharmaceutical Technology, March 2022 Issue
- Volume 46
- Issue 3
- Pages: 12
Lyophilized Master Mix
New England Biolabs Luna Probe One-Step RT-qPCR Mix with UDG enables sensitive, linear, real-time detection of target RNA sequences.
New England Biolabs (NEB) Luna Probe One-Step RT- quantitative polymerase chain reaction (qPCR) Mix with uracil-DNA glycosylase (UDG) enables sensitive, linear, real-time detection of target RNA sequences in a room temperature-stable format. When measured in NEB’s “dot in boxes” scoring method—a high-throughput data visualization tool that provides quality scores for qPCR outcomes—the LyoPrime Luna outperformed many competitor products and strongly matched the company’s liquid mix, according to the company.
The lyophilized mix contains murine RNase Inhibitor, deoxynucleoside triphosphate, and a passive reference dye. It incorporates thermolabile UDG, which is well-suited to RNA workflows, as well as deoxyuridine triphosphate to reduce carryover contamination risk between reactions.
Articles in this issue
over 3 years ago
The Shape of Dosage Formsover 3 years ago
Successfully Accelerating Formulation Strategiesover 3 years ago
Process Performance as a Means of Quality Managementover 3 years ago
The State of Phage Therapyover 3 years ago
Troubleshooting Using Predictive Maintenanceover 3 years ago
A New Route to Pharma GDP Compliance and Standardizationover 3 years ago
Empowering Protein Characterizationover 3 years ago
Cold Comfort for Bio/Pharmaover 3 years ago
Selecting and Optimizing the Right Manufacturing Partnerover 3 years ago
Standing in SolidarityNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.




